Natori K, Igeta M, Morimoto T, Nagahashi M, et al. Development and internal validation of a predictive model of overall and progression-free survival in eribulin-treated patients with breast cancer based on baseline peripheral blood parameters. Breast Cancer 2025 Feb 20. doi: 10.1007/s12282-025-01678.
PMID: 39979692